NHS England Innovation and Technology Tariff
NHS England have announced a new ‘Innovation and Technology Tariff’ to fast track the introduction of seven types of innovations during 2017/18. The Tariff is intended to help cut the difficulties experienced by innovators and clinicians in getting uptake and spread of technologies and services across the NHS. It will remove the need for multiple price negotiations between providers and suppliers, and instead guarantee automatic reimbursement when an approved innovation is used, whilst at the same time allowing NHS England and DH to negotiate national “bulk buy” discounts on behalf of hospitals, GPs and patients. For five of the six innovation categories providers would be reimbursed through local pricing. NHS England will then reimburse commissioners for this cost in addition to its commissioner allocations. The sixth category, treatment of lower urinary tract symptoms of benign prostatic hyperplasia as a day case, is already included in national prices.
The innovations will stay on the Tariff for as long as they provide benefit to patients, but they will be subject to annual review.
The following six innovations will be included in the Tariff:
- Guided mediolateral episiotomy scissors to minimise the risk of obstetric injury
- Arterial connecting systems to reduce bacterial contamination and the accidental administration of medication
- Pneumonia prevention systems which are designed to stop ventilator-associated pneumonia
- Web based applications for the self-management of chronic obstructive pulmonary disease
- Frozen microbiota transplantation for recurrent Clostridium difficile infection rates
- Prostatic urethral lift systems to treat lower urinary tract symptoms of benign prostatic hyperplasia as a day case
The Tariff will be operational from April 2017. To find out more: https://www.england.nhs.uk/2016/11/innov-tech-tariff/
Innovate UK - Biomedical Catalyst Awards 2017 Round 1
The Biomedical Catalyst awards fund innovative solutions to healthcare challenges. The maximum total project cost is £200,000. The aim of the feasibility studies award is to explore and evaluate the commercial potential of innovative scientific ideas through:
- reviewing research evidence and identifying possible applications
- assessing business opportunities
- investigating the intellectual property position
- validating initial concepts or existing pre-clinical work through experimental studies
- identifying areas for further development
These ideas should be for healthcare technologies and processes that will help provide:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
Key dates: Briefing event webinar for applicants, Monday 6 February 2017
Registration deadline, Wednesday 22 March 2017Application deadline, Wednesday 29 March 2017
Innovation in Health & Life Sciences Competition Briefing Round 2
Businesses can apply for a share of £15 million for projects that support SMEs to develop innovations in health and life sciences.
Key dates: Competition opens on 9 February 2017
Register before noon on 5th April 2017 (registration link will be available once the competition opens).
Apply before noon on 12th April 2017
The Longitude Prize
The Longitude Prize is a £10m prize fund that will reward a competitor that can develop a point–of–care diagnostic test that will conserve antibiotics for future generations and revolutionise the delivery of global healthcare. The test must be accurate, rapid, affordable and easy to use anywhere in the world.
To find out more: https://longitudeprize.org/challenge/antibiotics
Closing date: Entries judged every four months until December 2019, or until a winner is chosen.
NIHR i4i funding - Challenge Award (Mental Health)
“Challenge Awards are based on themed calls in areas of existing or emerging healthcare need. The next challenge awards competition will be launching on 11th January 2017, inviting applications for funding for innovative technological solutions in the area of mental health which have the potential to influence the patient care pathway; improving outcomes for those experiencing mental health problems.”
To find out more: http://www.nihr.ac.uk/funding-and-support/funding-for-research-studies/how-to-apply/research-programmes/invention-for-innovation/i4i-current-and-future-calls/i4i-challenge-awards.htm
Closing date: 5th April 2017 (Stage 1 Deadline)
Wellcome Trust Innovator Awards
Deadline: No deadline, apply at any time (decision received within 16 weeks of submission).
Amount: Up to £500k
Duration: Up to 24 months
Innovator Awards are open to researchers who are developing healthcare innovations that could have a major and measurable impact on human health.
Individuals and teams from not-for-profit and commercial organisations can apply. Organisations can be of any size, based anywhere in the world.
15-20 Innovator Awards are expected to be funded in 2017.
You can work in any discipline on any type of technology. Examples of technologies include:
• therapeutics (small molecules or biologics)
• digital technology
• regenerative medicine.
The work that you propose must be essential for developing your healthcare innovation.
At the moment, Wellcome are particularly interested in healthcare innovations that address problems in:
• mental health
• neurological disorders
• neglected tropical diseases.